Skip to content
Politically.com Search all
Menu

2025 · 3rd Quarter (July 1 - Sep 30)

PRIO PHARMA, INC.

Filed by ACTUM I, LLC.

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-08-03 06:26:15 UTC.

Source-reported fields

Filing overview

Type
3rd Quarter - Report
Posted
Oct 20, 2025
Income
$10,000.00
Expenses
Not reported
Registrant
ACTUM I, LLC
Filing UUID
ae278f4c-c7d5-4276-b965-924def697c93
Termination date
Not reported

Literal source text

Lobbying issues and bill citations

BUD · Budget/Appropriations

FY26 Defense Appropriations bill - Defense Health Program funding; H.R.5371 - Continuing Appropriations and Extensions Act, 2026, S.2882 - Continuing Appropriations and Extensions and Other Matters Act, 2026

Literal federal measure citations: H.R.5371, S.2882

DEF · Defense

FY26 Defense Appropriations bill - Defense Health Program funding; FY26 National Defense Authorization Act

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.